Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Meenakshi Kumari has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuropeptides in the Management of Alzheimer’s Disease: From Pathophysiology to Therapeutic Opportunities

    by Shraddha Tiwari, Shiv Kumar Yadav, Meenakshi Kumari, Thakur Dhakal, Nidhi Puranik

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory decline, cognitive impairment, and behavioral changes, ultimately leading to a loss of independence and reduced quality of life. Although understanding of the molecular basis of AD has advanced, effective disease-modifying therapies remain scarce. Neuropeptides are small protein-like signaling molecules that regulate diverse physiological processes, including mood, memory, and neuronal function. Growing evidence indicates that neuropeptides are promising therapeutic candidates for AD, particularly through modulation of neuroinflammation, synaptic plasticity, and amyloid-beta (Aβ) aggregation. Preclinical AD models show that neuroprotective neuropeptides, such as neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), and pituitary adenylate cyclase-activating peptide (PACAP), exert neuroprotective effects, enhance memory, and attenuate cognitive decline. This review summarizes current research on neuropeptide-based therapies for AD, detailing their molecular mechanisms, therapeutic actions, and the barriers to their clinical translation. We specifically highlight neuropeptides whose clinical potential in AD remains comparatively underrecognized, discuss strategies for optimizing their delivery and overcoming pharmacokinetic limitations, and outline future perspectives for integrating neuropeptide-based interventions into AD therapy.


  • Top Cited Papers
    Open Access

    Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies

    by Nidhi Puranik, Meenakshi Kumari, Shraddha Tiwari, Thakur Dhakal, Minseok Song

    Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and neuronal dysfunction. It is driven by the accumulation of amyloid-beta (Aβ) plaques, Tau protein hyperphosphorylation, oxidative stress, and neuroinflammation. Resveratrol (RSV) is a natural polyphenolic compound found in grapes, berries, and red wine that has garnered attention for its potential neuroprotective properties in combating AD. The neuroprotective effects of RSV are mediated through the activation of sirtuins (SIRT1), inhibition of Aβ aggregation, modulation of Tau protein phosphorylation, and the attenuation of oxidative stress and inflammatory responses. RSV also enhances mitochondrial function and promotes autophagy, which are important processes for maintaining neuronal health. Preclinical studies have demonstrated its efficacy in reducing Aβ burden, improving cognitive performance, and mitigating synaptic damage; however, challenges such as poor bioavailability, rapid metabolism, and limited blood–brain barrier penetration restrict its clinical applicability. Recent technological advances and selected modifications are being explored to overcome these limitations and enhance its therapeutic efficacy. This review summarizes the multifaceted neuroprotective mechanisms of RSV, the synergistic potential of natural compounds in enhancing neuroprotection, and the advancements in formulation strategies aimed at mitigating AD pathology. Leveraging the therapeutic potential of natural compounds represents a compelling paradigm shift for AD management, paving the way for future clinical applications.


  • Open Access

    Advanced Bioactive Polymers and Materials for Nerve Repair: Strategies and Mechanistic Insights

    by Nidhi Puranik, Shraddha Tiwari, Meenakshi Kumari, Shiv Kumar Yadav, Thakur Dhakal, Minseok Song

    Bioactive materials have recently shown potential in nerve repair and regeneration by promoting the growth of new cells, tissue repair, and restoring nerve function. These natural, synthetic, and hybrid materials offer a biomimetic structure, enhance cell attachment, and release bioactive molecules that promote the axonal extension of severed nerves. Scaffold-based preclinical studies have shown promising results on enhancing nerve repair; however, they are limited by the immune response and fabrication, scalability, and cost. Nevertheless, advances in manufacturing, including 3D bioprinting, and other strategies, such as gene editing by CRISPR, will overcome these shortcomings. The opportunity for the development of individualized approaches and specific treatment plans for each patient will also increase the effectiveness of bioactive materials for the treatment of nerve injuries. Combining bioactive materials with the neural interface can develop new reliable therapeutic solutions, particularly for neuroprosthetics. Finally, it is essential to stress a multidisciplinary focus, and future studies are needed to enhance the potential of bioactive materials for patients with nerve injuries and the field of regenerative medicine.


  • Effect of 6-Benzyl Aminopurine Different Concentration on Potato (Solanum tuberosum L.) Minitubers in Net House and in Field

    by Meenakshi Kumari

    Background: 6-benzyl aminopurine (BAP) is a dominant regulation in minitubers formation. BAP treatment enhances both Crop quantity and quality parameter like days to emergence, number of shoots, shoot length, root length, number of stolons, number of minitubers, potato shape index and fresh weight of minitubers. The purpose of this study was to optimise the effect of different concentrations of BAP on potato (Solanum tuberosum L.) minitubers in a net house and in field. Methods: The present investigation, effect of BAP different concentration on potato (Solanum tuberosum L.) microtubers and minitubers were done at Central Potato Research Institute Campus, Modipuram, Meerut during 2012-13 and 2013-14. This experiment design was split plot with five replications and three treatments. In vitro BAP treatments for microtuber growth parameters included three doses (0.75 mg/l, 1.5 mg/l and 2.25 mg/l). BAP treated microtubers were planted in net house, again in next season BAP treated minitubers were planted in field. Growth and yield parameters were recorded. Result: The concentration of BAP (1.5 mg/l) led to decrease in all parameters as compared to BAP at (2.25 mg/l) treatments in both the varieties. Same result was also observed in field.

  • Effect of Kinetin on Growth and Development of Microtubers of Potato (Solanum Tuberosum L.)

    by Kumari Meenakshi

    The present study was conducted at Central Research Potato Institute, Campus, Modipuram, India to assess the effect of kinetin on the growth and development of microtubers formation in vitro in two potato varieties Kufri Bahar and Kufri Surya. The lower concentration of kinetin (0.75 mg/l) showed decreased parameters like the number of microtubers, fresh weight of microtubers, eyes per microtuber. Higher concentration of kinetin (1.5 mg/l and 2.25 mg/l) led to increasing parameters as compared to control but decreased shoot length in both the varieties but kinetin at (2.25 mg/l) concentration gave best results for in vitro microtuberization for quality and yield parameters.


  • Open Access

    Modulation in growth and development of potato (Solanum tuberosum L.) microtubers by different concentration of 6-benzyl aminopurine

    by Meenakshi Kumari

    Two potato varieties namely, kufri bahar and kufri surya were tested for in vitro tuberization response to a same culture medium supplemented with three levels of 6-benzly aminopurine (0.75, 1.5 and 2.25 mg/L) in a completely randomized block design. The study was conducted in the Central Potato Research Institute (CPRI), Modipuram, Meerut Campus, and India during the period of 2012 to 2013 and 2013-2014. The objective was to determine optimum concentration of 6-benzly aminopurine for tuberization. Both varieties, exhibited a better response when the culture medium supplemented with 2.25 mg/L of 6-benzyl aminopurine than the other concentrations and control for mean values of number of days for tuber initiation microtuber number, fresh weight of microtubers and number of eyes per microtuber was found optimum and it may be useful to enhance tuber quality as well as crop growth under in vitro conditions at farmer and industrial levels. Key words: In vitro plantlets, potato cultivars, 6- benzyl aminopurine, in vitro plants.

  • Allelopathic Effects Of Eucalyptus Exudates On Vigna Radiata L.

    by Meenakshi Meenakshi, Ashok Kumar

    The allelopathic effect of leaf exudates of Eucalyptus camaldulensis Labill was examined on germination, growth, morphological and physiological parameters of Green gram (Vigna radiata L.). The leaf exudate of Eucalyptus releases toxic substances in the soil which are harmful for water table, soil microbes and fertility.